Sign in
Stories
Advancements in Brain Cancer, TTFields, and PEF Therapies
Share
Advances in Brain Cancer Treatments
Cancer Treatment Innovation Booms
FDA Clearance for NOX-A12 Phase 2 Trial
FDA Clears NOX-A12 for Glioblastoma
Genenta Science's Promising Immuno-Oncol...
Overview
API
Innovative brain cancer treatments, TTFields therapy, and Pulsed Electric Field (PEF) therapy are making groundbreaking strides in the medical field. HCA Healthcare's Johnston-Willis Hospital in the US is conducting a clinical trial combining focused ultrasound and immunotherapy for brain metastases from lung cancer. Novocure and Stanford University have established a research program to advance TTFields therapy, while Galvanize Therapeutics is conducting a clinical study using PEF therapy for stage IV non-small cell lung cancer or metastasis to the lung.
Ask a question
How could the advancements in brain cancer treatments, TTFields therapy, and PEF therapy influence the development of future medical technologies and treatments?
How might the success of these clinical trials impact the acceptance and adoption of these innovative brain cancer treatments?
What are the potential ethical considerations and implications for patients and healthcare providers regarding the use of TTFields and PEF therapies?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jun 2023
Jul 2023
Aug 2023
Sep 2023
Coverage